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 ORIGINAL ARTICLE 
 Neuropsychiatric symptoms are common in immunocompetent adult 
patients with Toxoplasma gondii acute lymphadenitis 
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 Abstract 
 Background: Chronic toxoplasmosis has been shown to be strongly associated with a range of neuropsychiatric effects 
including schizophrenia and suicide. However there have not been any prospective, community-based studies of the neu-
ropsychiatric effects of acute toxoplasmosis in adult immunocompetent patients.  Methods: Adult patients with a positive 
serum IgM anti-Toxoplasma gondii test result, in the context of an acute illness with lymphadenopathy, were invited to 
complete a questionnaire seeking information relating to the nature, severity, and duration of symptoms in the months 
following the diagnosis of acute toxoplasmosis.  Results: Laboratory testing identifi ed a total of 187 adults who had a posi-
tive serum IgM anti-T. gondii test result between 1 January and 30 November 2011. Consent to contact 108/187 (58%) 
patients was provided by their family doctor; 37 (34%) of these 108 patients completed and returned the questionnaire. 
Questionnaires from the 31/108 (29%) patients who reported swollen lymph nodes during their illness were included in 
the study. Fatigue (90%), headache (74%), diffi culty concentrating (52%), and muscle aches (52%) were the most com-
monly reported symptoms. These symptoms commonly persisted for at least 4 weeks. Twenty-seven of 31 (87%) subjects 
reported a moderate or severe reduction in their overall physical and mental health during the fi rst 2 months of illness. 
 Conclusions: Acute toxoplasmosis in immunocompetent adults commonly causes moderately severe neuropsychiatric symp-
toms that might result from replication of the organism in the central nervous system with consequent effects on brain 
function. Patients should be advised that such symptoms are common and reassured that they usually resolve completely 
within a few months. 
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 Introduction 
 Toxoplasmosis is a common human infection world-
wide. Most descriptions of acute Toxoplasma gondii 
infection state that it is either asymptomatic or the 
cause of a relatively benign, self-limited illness in the 
overwhelming majority of immunocompetent patients 
[1]. However there is a large body of evidence that 
chronic T. gondii infection is associated with signifi -
cant neuropsychiatric effects. For example, serologi-
cal evidence of chronic T. gondii infection is strongly 
associated with schizophrenia, self-directed violence 
in women, and with more subtle effects in a variety 
of neuropsychiatric tests [2 – 4]. Investigations in 
experimentally infected rodents have consistently 
shown effects of chronic T. gondii infection on rodent 
behaviour [5,6], which may be due to excessive 
 synthesis and secretion of dopamine by T. gondii-
infected cells [7]. 
 Previous studies of immunocompetent patients 
with acute toxoplasmosis have found that  ‘ asthenia ’ 
and  ‘ cephalea ’ [8],  ‘ fatigue ’ [9],  ‘ malaise ’ [10], and  ‘ con-
fusion ’ [11] are commonly reported symptoms. How-
ever the prevalence and duration of these symptoms, 
and the magnitude and duration of their effect on qual-
ity of life have not been adequately investigated in a 
population-based study. We surveyed adults with a 
recent serologically confi rmed diagnosis of acute toxo-
plasmosis associated with lymphadenitis to determine 
the prevalence and duration of neuropsychiatric symp-
toms and their impact on the patient ’ s quality of life. 
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 Methods 
 Adults resident in the greater Auckland area with a 
positive serum IgM anti-T. gondii test result (ADVIA 
Centaur  ®  and ADVIA Centaur XP  ®  systems, 
Siemens Healthcare Diagnostics Inc., NY, USA) in a 
blood sample tested between 1 January and 
30 November 2011 by Labtests NZ Ltd, the sole 
medical laboratory funded to perform diagnostic test-
ing of samples collected from outpatients at the request 
of their family doctor, were identifi ed from the com-
puterized laboratory database. These potential sub-
jects were sent a questionnaire in December 2011 
seeking information about the symptoms that they 
experienced during and after their illness.  Consent to 
contact these patients was sought and received from 
their family doctors, and written informed consent 
was sought and received from the patients. 
 Acute toxoplasmosis was diagnosed in subjects 
who had a serum IgM titre  "  1.0 and who reported 
symptoms of lymphadenopathy at the time of labo-
ratory testing. The questionnaire sought basic demo-
graphic information, information about past medical 
history, the features of the acute illness, and the 
duration and severity of any effects of the illness on 
the subject ’ s overall physical and mental health. 
Subjects were asked to score their overall physical 
and mental health for each month, from 2 months 
before the onset of acute toxoplasmosis to 6 months 
after the start of the illness, using a numeric score 
of: 1 ( “ the worst physical and mental health I can 
imagine ” ), 2 ( “ severe reduction in physical and 
mental health ” ), 3 ( “ moderate reduction in physical 
and mental health ” ), 4 ( “ minor reduction in physi-
cal and mental health ” ), or 5 ( “ best ever physical 
and mental health ” ). The questionnaire was devel-
oped for this study, based on reports of symptoms 
by patients previously cared for by one of the authors 
(MGT) and was piloted on 2 patients with acute 
toxoplasmosis who consulted one of the authors 
(MGT) during 2010. Patients were also invited to 
provide any further written information about the 
illness that they thought might be of interest to the 
researchers. 
 The study was approved by the New Zealand 
Ministry of Health Northern X Regional Ethics 
Committee. 
 Results 
 Between 1 January and 30 November 2011, Labtests 
tested 1929 samples from 1817 adult patients for 
IgM and IgG antibodies to T. gondii. Two hundred 
and eighty-three samples from 187 adult patients 
had a positive IgM result. The IgM anti-T. gondii 
titre was 1.0 – 2.0 in 76 patients, 2.01 – 10.0 in 33 
patients, and 10.01 – 100 in 78 patients. Consent to 
contact 108 patients who had a positive IgM anti-T. 
gondii result in a sample submitted to Labtests was 
provided by their family doctors. Questionnaires 
were sent to these 108 patients and were returned by 
37 patients. The study group comprised 31 patients 
who reported lymphadenopathy and had a serum 
anti-T. gondii IgM titre  "  1.0. 
 The median age of the subjects was 34 y (range 
10 – 66 y). Twenty-six of 31 (84%) subjects were 
female. The median IgM anti-T. gondii titre was 
15.31 (range 1.21 – 40). The median duration between 
the onset of symptoms of acute toxoplasmosis and 
completion of the questionnaire was 8 months (range 
1 – 15 months). Apart from 1 subject who had previ-
ously undergone a splenectomy, no subjects reported 
suffering from an immunosuppressing illness. None 
were being treated with immunosuppressive medica-
tions. Two subjects were pregnant at the onset of the 
toxoplasmosis illness. Sixteen described contact with 
cats or cat faeces, and 4 reported gardening with bare 
hands at least once a week. One subject was briefl y 
admitted to hospital because of fever (38.7 ° C), 
drenching sweats, muscle aches, and tachycardia 
(heart rate 115/min). Table I shows the clinical fea-
tures of the 31 subjects with acute toxoplasmosis. 
 Lymphadenopathy, a requirement for inclusion in 
the study, was reported by all subjects. The median 
duration of lymphadenopathy was 8 weeks (range 
1 – 65 weeks). Fatigue (90%), headache (74%), and 
diffi culty concentrating (52%) were commonly 
reported symptoms. Fatigue persisted for a median 
duration of 6 weeks, while headache and diffi culty 
concentrating persisted for median durations of 
5 weeks and 11 weeks, respectively. 
 In the 2 months before the onset of acute toxo-
plasmosis, 19 subjects gave their overall physical 
and mental health a score of 5 (best ever physical 
and mental health), 11 subjects a score of 4 (minor 
 Table I. Prevalence and duration of symptoms in immunocompetent 
adults with acute toxoplasmosis. 
Symptom Prevalence (%)
Median and 
range of 
duration ( n )
Swollen lymph nodes 31/31 (100) 8; 1 – 65 (30)
Fever 12/31 (39) 3; 1 – 12 (11)
Headache 23/31 (74) 5; 1 – 26 (19)
Fatigue 28/31 (90) 6; 1 – 47 (23)
Diffi culty concentrating 16/31 (52) 11; 1 – 47 (12)
Change in vision 4/31 (13) 4; 4 – 22 (3)
Muscle aches 16/31 (52) 4; 1 – 20 (14)
 Note. Data are presented as the number of subjects who reported 
the symptom, with the percentage in parenthesis, and as the 
median and range of duration of the symptom in weeks, with 
the number who reported the duration of the symptom in 
parenthesis. 
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 reduction in physical and mental health), and 1 sub-
ject a score of 3. However, in the 2 months after the 
onset of acute toxoplasmosis 2 subjects gave their 
overall physical and mental health a score of 1 (the 
worst physical and mental health I can imagine), 14 
subjects a score of 2 (severe reduction in physical and 
mental health), 11 subjects a score of 3 (moderate 
reduction in physical and mental health) and only 4 
subjects a score of 4 or 5. At 4 months after the onset 
of illness, 7/26 subjects (27%) gave their overall phys-
ical and mental health a score that was less than that 
in the 2 months before the onset of illness. Figure 1 
illustrates the mean scores of overall physical and 
mental health from 2 months before the onset of 
acute toxoplasmosis to 6 months after the illness 
began. The scores of overall physical and mental 
health in the month illness began (mean 2.93, stan-
dard deviation (SD) 0.96), at 1 month after illness 
began (mean 2.96, SD 0.96), and at 2 months after 
illness began (mean 3.31, SD 1.09) were all signifi -
cantly less than the score of overall physical and men-
tal health at 2 months before the onset of illness 
(mean 4.61, SD 0.57) ( p  #  0.001). 
 Twenty-four subjects provided further comments 
about the effects of their illness on their quality of 
life. A common theme among these comments was 
an increased feeling of fatigue. Several subjects 
reported not having fully recovered from this fatigue 
several months after the onset of illness. Two subjects 
who reported high levels of physical fi tness prior to 
the onset of toxoplasmosis, described marked reduc-
tions in exercise performance during their illness. 
One subject reported feeling  “ the most depressed 
that I have ever felt in my life ” . Another reported 
severe dizziness and vertigo during the fi rst 2 weeks 
after the onset of illness, which then gradually 
resolved over the subsequent 6 months. 
 Discussion 
 We found that fatigue, headache, and diffi culty con-
centrating were common symptoms in patients with 
acute Toxoplasma lymphadenitis and that these and 
other symptoms caused a signifi cant deterioration in 
patients ’ overall mental and physical health, which 
frequently persisted for 2 to 3 months. Previous 
descriptions of acute toxoplasmosis in the immuno-
competent adult have characterized it as a  “ benign, 
self-limited, non-specifi c illness that rarely needs 
treatment ” [1]. It is widely accepted that a signifi cant 
proportion of immunocompetent people who acquire 
T. gondii infection in adult life remain asymptomatic 
 Figure 1. Box and whisker plot of scores of overall physical and mental health from 2 months before the onset of acute toxoplasmosis to 
6 months after the onset of illness. 
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or experience very mild symptoms. We chose to 
study adult patients who had lymphadenopathy in 
the context of an illness that led their family doctor 
to suspect acute toxoplasmosis. Our fi ndings demon-
strate that such patients may suffer several weeks of 
symptoms with signifi cant distress. Perhaps because 
acute toxoplasmosis is commonly perceived as a 
minor illness, there have not been any randomized 
controlled trials of treatment with agents active 
against T. gondii in immunocompetent adults with 
acute toxoplasmosis. Our results indicate that in 
patients with lymphadenitis as a component of their 
acute infection, the symptoms of acute toxoplasmosis 
are suffi ciently common, severe, and prolonged to 
warrant trials of such treatment. In the absence of 
any evidence for benefi t from treatments active against 
T. gondii, patients with acute Toxoplasma lymph-
adenitis should at least be advised of the commonly 
expected symptoms and reassured that while such 
symptoms may be relatively severe, they will usually 
resolve within a few months. 
 Our study has a number of weaknesses. A relatively 
small proportion of potential subjects completed the 
questionnaire, and there was a marked female bias in 
the respondents. We relied on self- reported symptoms 
and did not have access to any clinical information 
other than the anti-T. gondii antibody titres. We did 
not include a control group, and relied on patients ’ 
subjective assessment of their symptoms, reported 
some months after the onset of illness, which may have 
resulted in recall bias. However the strengths of our 
study include the fact that we attempted to recruit all 
adult patients with a diagnosis of acute Toxoplasma 
lymphadenitis made by their family doctor, rather 
than accumulate patients referred to a hospital or spe-
cialist practice which inevitably would have resulted 
in the selection of a biased cohort of patients. We 
obtained data concerning the duration of symptoms 
and the duration of the effects of the illness on the 
patient ’ s overall health, information that is not avail-
able from previous articles that have reported only the 
symptoms present in patients at the time of diagnosis. 
We consider it likely that of the 108 subjects sent the 
questionnaire those with the most severe symptoms 
would have been more likely to complete and return 
the questionnaire. However, even if the 76 subjects 
who did not respond to our questionnaire had no sig-
nifi cant neuropsychiatric symptoms associated with 
their episode of acute toxoplasmosis, our results still 
indicate that relatively severe and prolonged symp-
toms occur in at least 15 – 20% of patients. 
 Accumulating evidence suggests that infection of 
the central nervous system by T. gondii is common 
in immunocompetent experimentally infected ani-
mals and results in profound effects on their behav-
iour. Rodents with chronic T. gondii infection appear 
normal in all other respects but have a reversal of 
their normal aversion to the smell of domestic cats 
and other felines [5,6]. This alteration in rodent 
behaviour is believed to enhance predation of infected 
rodents by felines in the wild and thus facilitate the 
T. gondii lifecycle. There is strong evidence that 
increased secretion of dopamine by neural cells 
infected with T. gondii may be responsible for this 
alteration in the behaviour of chronically infected 
rodents [7]. 
 The high incidence of toxoplasmic encephalitis 
in patients with severe immunosuppression sug-
gests that chronic infection of the central nervous 
system is a very common consequence of acute 
T. gondii infection in humans. It is possible that 
persistent infection of the central nervous system 
is responsible for the strong association between 
schizophrenia and self harm and chronic T. gondii 
infection [2,3], and for the more subtle alterations 
in behaviour seen when various population groups 
with serologic evidence of chronic T. gondii 
 infection are compared with uninfected controls 
[4]. Our fi ndings raise the possibility that infection 
of the central nervous system may be the cause of 
the moderately severe neuropsychiatric symptoms 
that we found occurring relatively commonly in 
patients with acute toxoplasmosis. Future prospec-
tive studies of acute toxoplasmosis may help to 
more precisely determine the prevalence, severity, 
and duration of these symptoms and elucidate the 
underlying pathological processes. We hope that 
the fi ndings of this study will result in a more 
 widespread appreciation that for many patients 
acute toxoplasmosis is a moderately disabling ill-
ness with relatively severe and prolonged neurop-
sychiatric effects. 
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